(LZB) La-Z-Boy - Overview
Stock: Recliners, Sofas, Chairs, Bedroom Sets, Dining Sets
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.28% |
| Yield on Cost 5y | 2.46% |
| Yield CAGR 5y | 10.05% |
| Payout Consistency | 85.6% |
| Payout Ratio | 32.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 32.5% |
| Relative Tail Risk | -8.76% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.33 |
| Alpha | -29.96 |
| Character TTM | |
|---|---|
| Beta | 0.864 |
| Beta Downside | 0.513 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.87% |
| CAGR/Max DD | 0.38 |
Description: LZB La-Z-Boy January 15, 2026
La-Z-Boy Inc. (NYSE:LZB) designs, manufactures, imports and sells upholstered and casegoods furniture across the United States, Canada and other markets. It operates two primary channels: a Wholesale segment that supplies recliners, sofas, sectionals and wood-frame pieces to its own La-Z-Boy Galleries, Comfort Studios, dealer networks and other retailers; and a Retail segment that sells directly to consumers through company-owned stores, the Joybird e-commerce platform, and licensed-brand products.
Key recent metrics: FY 2023 revenue was approximately $2.2 billion, with an adjusted operating margin near 6 %-roughly in line with the broader home-furnishings industry. E-commerce now accounts for about 15 % of total sales, driven largely by Joybird’s urban-store footprint and online traffic. The segment’s performance is closely tied to housing-starts and consumer-confidence trends; a 5 % YoY decline in U.S. housing starts in Q4 2023 correlated with a 3 % dip in same-store sales, underscoring sensitivity to macro-demand cycles.
For a deeper, data-driven view of La-Z-Boy’s valuation and risk profile, you may find the analysis on ValueRay worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 90.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.65 > 1.0 |
| NWC/Revenue: 18.96% < 20% (prev 18.56%; Δ 0.40% < -1%) |
| CFO/TA 0.10 > 3% & CFO 204.6m > Net Income 90.4m |
| Net Debt (164.4m) to EBITDA (257.0m): 0.64 < 3 |
| Current Ratio: 1.94 > 1.5 & < 3 |
| Outstanding Shares: last quarter (41.4m) vs 12m ago -1.82% < -2% |
| Gross Margin: 43.79% > 18% (prev 0.43%; Δ 4335 % > 0.5%) |
| Asset Turnover: 108.4% > 50% (prev 107.4%; Δ 1.05% > 0%) |
| Interest Coverage Ratio: 289.8 > 6 (EBITDA TTM 257.0m / Interest Expense TTM 466.0k) |
Altman Z'' 3.57
| A: 0.20 (Total Current Assets 823.3m - Total Current Liabilities 423.7m) / Total Assets 1.96b |
| B: 0.31 (Retained Earnings 608.3m / Total Assets 1.96b) |
| C: 0.07 (EBIT TTM 135.1m / Avg Total Assets 1.94b) |
| D: 0.71 (Book Value of Equity 646.3m / Total Liabilities 907.3m) |
| Altman-Z'' Score: 3.57 = A |
Beneish M -3.26
| DSRI: 0.83 (Receivables 138.3m/163.2m, Revenue 2.11b/2.07b) |
| GMI: 0.99 (GM 43.79% / 43.35%) |
| AQI: 0.94 (AQ_t 0.17 / AQ_t-1 0.18) |
| SGI: 1.02 (Revenue 2.11b / 2.07b) |
| TATA: -0.06 (NI 90.4m - CFO 204.6m) / TA 1.96b) |
| Beneish M-Score: -3.26 (Cap -4..+1) = AA |
What is the price of LZB shares?
Over the past week, the price has changed by +4.19%, over one month by -0.56%, over three months by +26.13% and over the past year by -11.26%.
Is LZB a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the LZB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 42.5 | 9.5% |
| Analysts Target Price | 42.5 | 9.5% |
| ValueRay Target Price | 41.5 | 7% |
LZB Fundamental Data Overview February 04, 2026
P/S = 0.7289
P/B = 1.4447
P/EG = 2.01
Revenue TTM = 2.11b USD
EBIT TTM = 135.1m USD
EBITDA TTM = 257.0m USD
Long Term Debt = 1.86m USD (from longTermDebtTotal, last fiscal year)
Short Term Debt = 82.7m USD (from shortTermDebt, last quarter)
Debt = 502.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 164.4m USD (from netDebt column, last quarter)
Enterprise Value = 1.70b USD (1.54b + Debt 502.9m - CCE 338.5m)
Interest Coverage Ratio = 289.8 (Ebit TTM 135.1m / Interest Expense TTM 466.0k)
EV/FCF = 13.70x (Enterprise Value 1.70b / FCF TTM 124.1m)
FCF Yield = 7.30% (FCF TTM 124.1m / Enterprise Value 1.70b)
FCF Margin = 5.89% (FCF TTM 124.1m / Revenue TTM 2.11b)
Net Margin = 4.29% (Net Income TTM 90.4m / Revenue TTM 2.11b)
Gross Margin = 43.79% ((Revenue TTM 2.11b - Cost of Revenue TTM 1.18b) / Revenue TTM)
Gross Margin QoQ = 44.24% (prev 42.50%)
Tobins Q-Ratio = 0.87 (Enterprise Value 1.70b / Total Assets 1.96b)
Interest Expense / Debt = 0.02% (Interest Expense 110.0k / Debt 502.9m)
Taxrate = 26.73% (10.6m / 39.6m)
NOPAT = 99.0m (EBIT 135.1m * (1 - 26.73%))
Current Ratio = 1.94 (Total Current Assets 823.3m / Total Current Liabilities 423.7m)
Debt / Equity = 0.48 (Debt 502.9m / totalStockholderEquity, last quarter 1.04b)
Debt / EBITDA = 0.64 (Net Debt 164.4m / EBITDA 257.0m)
Debt / FCF = 1.32 (Net Debt 164.4m / FCF TTM 124.1m)
Total Stockholder Equity = 1.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.65% (Net Income 90.4m / Total Assets 1.96b)
RoE = 8.83% (Net Income TTM 90.4m / Total Stockholder Equity 1.02b)
RoCE = 13.16% (EBIT 135.1m / Capital Employed (Equity 1.02b + L.T.Debt 1.86m))
RoIC = 9.66% (NOPAT 99.0m / Invested Capital 1.02b)
WACC = 6.86% (E(1.54b)/V(2.04b) * Re(9.10%) + D(502.9m)/V(2.04b) * Rd(0.02%) * (1-Tc(0.27)))
Discount Rate = 9.10% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.35%
[DCF Debug] Terminal Value 83.49% ; FCFF base≈118.3m ; Y1≈129.3m ; Y5≈163.5m
Fair Price DCF = 84.58 (EV 3.65b - Net Debt 164.4m = Equity 3.49b / Shares 41.2m; r=6.86% [WACC]; 5y FCF grow 10.60% → 2.90% )
EPS Correlation: -68.75 | EPS CAGR: -52.06% | SUE: -4.0 | # QB: 0
Revenue Correlation: -63.08 | Revenue CAGR: -2.37% | SUE: 0.29 | # QB: 0
EPS current Year (2026-04-30): EPS=2.71 | Chg30d=+0.173 | Revisions Net=+2 | Growth EPS=-7.2% | Growth Revenue=+1.5%
EPS next Year (2027-04-30): EPS=3.04 | Chg30d=+0.247 | Revisions Net=+2 | Growth EPS=+12.3% | Growth Revenue=+2.4%